Skip to main content
logo
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.120
-0.040 (-3.45%)
At close: Sep 1, 2026, 4:00 PM EDT
1.100
-0.020 (-1.79%)
After-hours: Sep 1, 2026, 5:31 PM EDT

Cocrystal Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.33-----
Revenue Growth
------
Gross Profit
-5.76-5.06-12.54-15.17-12.39-8.79
Operating Income
-10.11-9.02-17.88-21.16-18.14-14.22
Net Income
-9.94-8.83-17.5-17.98-38.84-14.19
Earnings Per Share
-0.76-0.78-1.72-1.86-4.77-1.93
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.177.039.8626.3537.1458.71
Total Debt
1.341.511.811.850.30.53
Net Cash (Debt)
0.835.528.0524.536.8558.17
Net Cash Growth
-73.36%-31.46%-67.13%-33.51%-36.66%79.46%
Net Cash Per Share
0.060.490.792.544.527.90

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.95-8.19-16.49-14.67-21.44-12.72
Capital Expenditures
-0.01-0.01-0.01-0.12-0.07-0.05
Free Cash Flow
-7.97-8.2-16.49-14.78-21.51-12.77
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-3063.64%-----
Profit Margin
-3011.51%-----
FCF Margin
-2413.94%-----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
67.71-----